CTL follow up in vaccination using recombinant, multimeric, MHC class I molecules, loaded with homogenous CTL epitopes

Project Information

Grant agreement ID: BIO4980214

Project closed

Start date 1 December 1998

End date 31 May 2001

Funded under

• Specific research, technological development and demonstration programme in the field of biotechnology, 1994-1998

Total cost No data

EU contribution No data

Coordinated by

Immunotech SA
France

Programme(s)

• FP4-BIOTECH 2 - Specific research, technological development and demonstration programme in the field of biotechnology, 1994-1998

Topic(s)

• 0502 - Transdisease vaccinology

Call for proposal

Data not available

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

Immunotech SA

• EU contribution: No data
• Address: 130,Av. de Lattre de Tassigny 130 ; 13276 Marseille ; France
• Total cost: No data

Participants (7)

Academisch Ziekenhuis Leiden

Netherlands

• EU contribution: No data
• Address: 2300 RC Leiden
• Total cost: No data

Eberhard-Karls-Universität Tübingen

Germany

• EU contribution: No data
• Address: 15,Auf den Morgenstelle ; 72076 Tübingen
• Total cost: No data

Fondazione Salvatore Maugeri - Clinica del Lavoro e della Riabilitazione

Italy

• EU contribution: No data
• Address: Via Adolfo Ferrata 8 ; 27100 Pavia
• Total cost: No data

Institut Pasteur

France

• EU contribution: No data
• Address: Rue du Docteur Roux 25 ; 75724 Paris
• Total cost: No data

Medical Research Council

United Kingdom

• EU contribution: No data
• Address: John Radcliffe hospital ; OX3 9DS Headington
• Total cost: No data

UNIVERSITY OF BIRMINGHAM

United Kingdom

• EU contribution: No data
• Address: Edgbaston, The Medical Block ; B15 2TA BIRMINGHAM
• Total cost: No data

Université de Nantes

France

• EU contribution: No data
• Address: Quai Moncousu 9 ; 44035 Nantes
• Total cost: No data